Arch Virol

1. GROSS S, Dalphin L, Dor F, Ramanah R, et al
   Frequent detection of high-risk HPV types other than HPV 16/18 in a cohort of French women who claimed to have been vaccinated.
   Arch Virol. 2026;171:262.
   

   >> Share

   
   

   
   BMJ

2. WASSWA H
   Ebola: WHO declares Uganda free of virus, but doctors express reservations about new vaccine trial.
   BMJ. 2026;394:e100708.
   

   >> Share

   
   
3. LANG K
   What are the real risks of covid vaccines and miscarriage?
   BMJ. 2026;394:e100682.
   

   >> Share

   
   
4. IACOBUCCI G
   Shingles vaccine is linked to lower risk of heart disease and stroke, study suggests.
   BMJ. 2026;394:e100711.
   

   >> Share

   
   
5. BARANIUK C
   Dolly Parton's major contributions to vaccines and public health.
   BMJ. 2026;394:e100694.
   

   >> Share

   
   
6. LIANG L
   US kindergarten vaccinations drop to new low.
   BMJ. 2026;394:e100647.
   

   >> Share

   
   

   
   J Infect Dis

7. WATTIAU P, Omar SV, Joseph L, Demoitie MA, et al
   Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccine.
   J Infect Dis. 2026 Aug 28:jiag428. doi: 10.1093.
   

   >> Share

   
   
8. KHAYARGOLI P, Grace D, Cox J, de Pokomandy A, et al
   HPV vaccine effectiveness against prevalent HPV by age, years sexually active before vaccination, and HIV status in gay, bisexual, and other men who have sex with men, 2019-2021.
   J Infect Dis. 2026 Aug 26:jiag426. doi: 10.1093.
   

   >> Share

   
   

   
   J Virol

9. KUMAR S, Lai L, Ellis ML, Patel A, et al
   Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine doses.
   J Virol. 2026 Aug 26:e0074926. doi: 10.1128/jvi.00749.
   

   >> Share

   
   

   
   Lancet

10. HALBROOK M, Merritt S, Hoff NA, Mukadi P, et al
    Bundibugyo virus glycoprotein seroreactivity following recombinant vesicular stomatitis virus-Zaire Ebola virus glycoprotein vaccination in outbreak-affected populations of the Democratic Republic of the Congo: a longitudinal cohort study.
    Lancet. 2026 Aug 25:S0140-6736(26)01608-9. doi: 10.1016/S0140-6736(26)01608.
    

    >> Share

    
    

    
    Nat Immunol

11. JOHNSTON TS, Li SH, Painter MM, Swaminathan D, et al
    Potent type-specific de novo antibodies complement broadly reactive imprinted antibodies in immune responses to SARS-CoV-2 variants.
    Nat Immunol. 2026;27:1874-1886.
    

    >> Share

    
    

    
    Nat Med

12. CORSI-ZUELLI F, Li F, Upthegrove R, Todd JA, et al
    Recombinant shingles vaccination and the risk of cardiovascular events.
    Nat Med. 2026 Aug 26. doi: 10.1038/s41591-026-04606.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

13. THURAU NM, Tometten I, Lubke N, Michels BE, et al
    Immunologic Response and Clinical Course After Off-label Nonavalent HPV Vaccination in Juvenile-onset Recurrent Respiratory Papillomatosis Patients.
    Pediatr Infect Dis J. 2026 Aug 26. doi: 10.1097/INF.0000000000005381.
    

    >> Share

    
    

    
    PLoS One

14. ARTEMCHUK O, Chakhunashvili G, Finci I, Rojas M, et al
    Factors associated with influenza vaccine uptake among healthcare workers in Georgia, 2021-2024.
    PLoS One. 2026;21:e0356495.
    

    >> Share

    
    
15. LIAQAT A, Dastgir K, Sajjad M, Rehman HM, et al
    In silico framework for designing and validating a multi-stage subunit vaccine against Tuberculosis using reverse vaccinology approach.
    PLoS One. 2026;21:e0356788.
    

    >> Share

    
    
16. EKHOLUENETALE M
    Decomposing socioeconomic inequalities in COVID-19 vaccination uptake among Nigerian women of reproductive age: A further analysis of population-based data.
    PLoS One. 2026;21:e0357171.
    

    >> Share

    
    
17. BANDOH DA, Dzodzomenyo M, Kenu E, Dennis FE, et al
    Enteric Pathogens in children under five with diarrhoea in a rotavirus vaccinated population in Coastal Ghana, 2023.
    PLoS One. 2026;21:e0356904.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

18. MONTGOMERIE I, McKenzie RE, Palmer OR, Mason NC, et al
    Engineering antigenic breadth against SARS-CoV-2 by pairing divergent RBDs within a single mRNA immunogen.
    Proc Natl Acad Sci U S A. 2026;123:e2602574123.
    

    >> Share

    
    

    
    Vaccine

19. HARIYANTO TI
    Measles resurgence in Indonesia: the intersection of immunity gaps, subnational heterogeneity, and vaccine confidence.
    Vaccine. 2026;91:129085.
    

    >> Share

    
    
20. NITTA T, Kashiyama T, Matsumoto Y, Toyoda T, et al
    Residual DNA in COVID-19 mRNA vaccines: Regulatory context and misinformation.
    Vaccine. 2026;91:129080.
    

    >> Share

    
    
21. GUTIERREZ AM, Do MH, Motta M
    Psychometric validity evidence for a measure of trust in U.S. public health actors for vaccine information.
    Vaccine. 2026;91:129026.
    

    >> Share

    
    
22. GENSOROWSKY D, Surmann B, Meyer AC, Poshtiban A, et al
    Corrigendum to "Outpatient care intensity and influenza vaccination: evidence from Germany" [Vaccine 70 (2026) 128038].
    Vaccine. 2026;90:129062.
    

    >> Share

    
    
23. NUNES JPDS, Daher IP, Pires ADS, Yamamoto MM, et al
    Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.
    Vaccine. 2026;91:129073.
    

    >> Share

    
    
24. PORTILHO AI, Andreata-Santos R, Duarte-Barbosa M, Chaves APC, et al
    Functional neutralizing and bactericidal antibody responses induced by dual-target immunization with SARS-CoV-2 RBD and Neisseria meningitidis antigens in mice.
    Vaccine. 2026;90:129011.
    

    >> Share

    
    
25. ISLAM MA, Zehra SM, Kazi Z, Ather S, et al
    A multi-center, open-labelled, randomized controlled extended phase III non-inferiority clinical trial to evaluate the immunogenicity and tolerability of poliomyelitis vaccine (Vero cells), inactivated, Sabin strains administered with or without routi
    Vaccine. 2026;91:129095.
    

    >> Share

    
    
26. LI Q, Bai G
    Central nervous system safety risks and evaluation strategies for mucosal vaccines: A review.
    Vaccine. 2026;91:129084.
    

    >> Share

    
    
27. MACKENZIE LJ, Bousie JA, Newman P, Preston P, et al
    Muscle size matters: making paediatric vaccination safe for all - a pilot study.
    Vaccine. 2026;91:129076.
    

    >> Share

    
    
28. SCHRARSTZHAUPT IN, Diaz-Quijano FA
    Effectiveness of COVID-19 vaccination schedules against severe COVID-19 in children aged 6 months to 4 years in Brazil: A population-based cohort study (2023-2024).
    Vaccine. 2026;91:129096.
    

    >> Share

    
    
29. BOTT L, Liu J, Challenger A, Powell E, et al
    Myth-busting influenza and fear of adverse reactions in healthcare workers: two experimental studies on vaccination intentions.
    Vaccine. 2026;91:129086.
    

    >> Share

    
    
30. ANAND A, Jepkosgei D, Mwachari C, Jalang'o R, et al
    Immunogenicity of type 2 novel oral poliovirus vaccine administered in outbreak response, Kenya 2023: an observational cohort study.
    Vaccine. 2026;91:128969.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share